Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancerChristine Lundgren, Maria Ekholm, Pär‐Ola Bendahl et al.|Breast Cancer Research and Treatment|2019Cited by 33
Good adherence to adjuvant endocrine therapy in early breast cancer – a population-based study based on the Swedish Prescribed Drug RegisterChristine Lundgren, Maria Ekholm, Henrik Lindman et al.|Acta Oncologica|2018Cited by 26
Real World Evaluation of the Prosigna/PAM50 Test in a Node-Negative Postmenopausal Swedish Population: A Multicenter StudyUna Kjällquist, Johan Hartman, Balázs Ács et al.|Cancers|2022Cited by 21
Adherence to and optimization of guidelines for Risk of Recurrence/Prosigna testing using a machine learning model: a Swedish multicenter studyUna Kjällquist, Alexios Matikas, Nikolaos Tsiknakis et al.|Research Square|2024Cited by 0
ONCOLOGISTS’ EXPERIENCES OF DECISION-MAKING IN LATER LINES OF METASTATIC BREAST CANCER TREATMENT: BALANCING BETWEEN AUTONOMY AND AUTHORITYKarolina Larsson, Matilda Liljedahl, Elisabeth Vastergaard et al.|The Breast|2025Cited by 0